KRAS Mutation Analysis by PCR

Submitted by Anonymous (not verified) on
Code
MOG-KRSX-01AX
Test
Active-Compendium
81275, 81276
81479
Clinical
Oncology,Pathology
FFPE solid tumor tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives.
Solid Tumors
Biliary tract
Bladder
Cervix
Colorectal
Endometrium
Gastroesophageal
GIST/Soft Tissue
Liver
Lung
Ovary
Pancreas
Prostate
Salivary Gland
Molecular
Global
Flag Active
True
Orderable Test Description
The KRAS Mutation Analysis Assay is a real-time PCR-based assay designed to detect somatic mutations in exons 2, 3 and 4 of the KRAS gene. This assay is designed to detect the following KRAS mutations: Exon 2 - G12C, G12A/D/R/V/S and G13D; Exon 3 - A59E/G/T and Q61H/L/R; Exon 4 - K117N/R/E and A146T/P/V. Testing is available separately or in combination with BRAF, HRAS and NRAS in the RAS/RAF Panel.
Orderable Turn Around Time
7 Days
Keywords
kras
kras mutation
codon 117
codon 146
exon 4
includes G12C mutation
PCR
Meta Description
KRAS Mutation Analysis Assay is a real-time PCR-based assay designed to detect somatic mutations in exons 2, 3 and 4 of the KRAS gene
Extra Note

Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.

Orderable Biomarkers
KRAS
NY Approved
True
Orderable Biomarkers JSON
{"DNA Sequencing": {"SNVs + Indels": ["KRAS"]}}
Keywords string
kras, kras mutation, codon 117, codon 146, exon 4, includes G12C mutation, PCR KRAS Mutation Analysis by PCR
Title URL
kras-mutation-analysis-by-pcr